Michael Gelband’s Alignment Healthcare ALHC Stock Holding History

Michael Gelband’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.19M	Buy	+134,066	New	+$2.57M	0.02%	639
2026 Q1	–	Sell	-381,202	Closed	-$7.53M	–	1518
2025 Q4	$7.53M	Buy	+381,202	New	+$6.85M	0.06%	335
2025 Q3	–	Sell	-56,108	Closed	-$786K	–	1494
2025 Q2	$786K	Buy	+56,108	New	+$903K	0.01%	1031
2024 Q1	–	Sell	-396,238	Closed	-$3.41M	–	1456
2023 Q4	$3.41M	Sell	396,238 -436,217	-52%	-$3.19M	0.02%	430
2023 Q3	$5.78M	Buy	832,455 +62,207	+8%	+$375K	0.06%	341
2023 Q2	$4.43M	Sell	770,248 -402,364	-34%	-$2.6M	0.04%	495
2023 Q1	$7.46M	Buy	1,172,612 +1,063,422	+974%	+$10.1M	0.06%	380
2022 Q4	$1.28M	Sell	109,190 -15,800	-13%	-$192K	0.02%	842
2022 Q3	$1.48M	Buy	124,990 +63,619	+104%	+$928K	0.02%	937
2022 Q2	$700K	Buy	61,371 +19,918	+48%	+$210K	0.01%	1233
2022 Q1	$466K	Buy	41,453 +21,800	+111%	+$196K	0.01%	1573
2021 Q4	$276K	Buy	+19,653	New	+$344K	﹤0.01%	1694
2021 Q2	–	Sell	-14,765	Closed	-$324K	–	2290
2021 Q1	$324K	Buy	+14,765	New	+$289K	﹤0.01%	1613

Other funds holding ALHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's ALHC Position: Q2 2026 in Review

Michael Gelband opened a new position in Alignment Healthcare (ALHC) in Q2 2026: 134,066 shares worth $3.19M. The stake represents 0.02% of the portfolio and ranks #639 among its holdings. This is a return to the name: Michael Gelband previously reported a position in ALHC as recently as Q4 2025.

Michael Gelband first reported a position in ALHC in Q1 2021 and has held it in 13 quarters since. The position peaked at $7.53M in Q4 2025. 321 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

Michael Gelband held 134,066 shares of Alignment Healthcare worth $3.19M as of Q2 2026.
Alignment Healthcare was a new Michael Gelband position in Q2 2026.
Alignment Healthcare made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #639 holding.
Michael Gelband first reported a position in Alignment Healthcare in Q1 2021 and has held it in 13 quarters since.
Michael Gelband's Alignment Healthcare position peaked at $7.53M in Q4 2025.
321 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.